219 related articles for article (PubMed ID: 29363879)
21. Clinical and prognostic value of hTERT mRNA expression in patients with non-small-cell lung cancer.
Zalewska-Ziob M; Dobija-Kubica K; Biernacki K; Adamek B; Kasperczyk J; Bruliński K; Ostrowska Z
Acta Biochim Pol; 2017; 64(4):641-646. PubMed ID: 29141053
[TBL] [Abstract][Full Text] [Related]
22. Orientia tsutsugamushi modulates cellular levels of NF-κB inhibitor p105.
Wangsanut T; Brann KR; Adcox HE; Carlyon JA
PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009339. PubMed ID: 33857149
[TBL] [Abstract][Full Text] [Related]
23. Strong cytoplasmic expression of NF-κB/p65 correlates with a good prognosis in patients with triple-negative breast cancer.
Baba M; Takahashi M; Yamashiro K; Yokoo H; Fukai M; Sato M; Hosoda M; Kamiyama T; Taketomi A; Yamashita H
Surg Today; 2016 Jul; 46(7):843-51. PubMed ID: 26494004
[TBL] [Abstract][Full Text] [Related]
24. CUG-binding protein 1 (CUGBP1) expression and prognosis of non-small cell lung cancer.
Jiao W; Zhao J; Wang M; Wang Y; Luo Y; Zhao Y; Tang D; Shen Y
Clin Transl Oncol; 2013 Oct; 15(10):789-95. PubMed ID: 23359188
[TBL] [Abstract][Full Text] [Related]
25. Increased staining for phosphorylated AKT and nuclear factor-kappaB p65 and their relationship with prognosis in epithelial ovarian cancer.
Guo RX; Qiao YH; Zhou Y; Li LX; Shi HR; Chen KS
Pathol Int; 2008 Dec; 58(12):749-56. PubMed ID: 19067848
[TBL] [Abstract][Full Text] [Related]
26. NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes.
Heissmeyer V; Krappmann D; Wulczyn FG; Scheidereit C
EMBO J; 1999 Sep; 18(17):4766-78. PubMed ID: 10469655
[TBL] [Abstract][Full Text] [Related]
27. Potential biomarkers involving IKK/RelA signal in early stage non-small cell lung cancer.
Jin X; Wang Z; Qiu L; Zhang D; Guo Z; Gao Z; Deng C; Wang F; Wang S; Guo C
Cancer Sci; 2008 Mar; 99(3):582-9. PubMed ID: 18215193
[TBL] [Abstract][Full Text] [Related]
28. Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC).
Zhao Q; Yue J; Zhang C; Gu X; Chen H; Xu L
Oncotarget; 2015 Oct; 6(30):29335-46. PubMed ID: 26336823
[TBL] [Abstract][Full Text] [Related]
29. Regulation of NF-κB by the p105-ABIN2-TPL2 complex and RelAp43 during rabies virus infection.
Besson B; Sonthonnax F; Duchateau M; Ben Khalifa Y; Larrous F; Eun H; Hourdel V; Matondo M; Chamot-Rooke J; Grailhe R; Bourhy H
PLoS Pathog; 2017 Oct; 13(10):e1006697. PubMed ID: 29084252
[TBL] [Abstract][Full Text] [Related]
30. [Activation of nuclear factor-κB subunit p50/p65 enhances gefitinib resistance of lung adenocarcinoma H1650 cell line].
Pan Y; Huang SC; Wang X; Gong WX; Liang CW; DU JX; Peng DX; Xie Y; Zheng LP; Zhang N; Quan W
Nan Fang Yi Ke Da Xue Xue Bao; 2018 May; 38(5):584-590. PubMed ID: 29891456
[TBL] [Abstract][Full Text] [Related]
31. Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer.
You Q; Guo H; Xu D
Drug Des Devel Ther; 2015; 9():5087-97. PubMed ID: 26366059
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of NF-κB expression in non-small cell lung cancer: A meta-analysis.
Gu L; Wang Z; Zuo J; Li H; Zha L
PLoS One; 2018; 13(5):e0198223. PubMed ID: 29813121
[TBL] [Abstract][Full Text] [Related]
33. NF-κB/p65 expression before and after treatment in rectal cancer patients undergoing neoadjuvant (chemo)radiotherapy and surgery: prognostic marker for disease progression and survival.
Voboril R; Rychterova V; Voborilova J; Kubecova M; Fanta J; Dvorak J
Neoplasma; 2016; 63(3):462-70. PubMed ID: 26952512
[TBL] [Abstract][Full Text] [Related]
34. RelA NF-κB subunit activation as a therapeutic target in diffuse large B-cell lymphoma.
Zhang M; Xu-Monette ZY; Li L; Manyam GC; Visco C; Tzankov A; Wang J; Montes-Moreno S; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; Han van Krieken J; Huh J; Ponzoni M; Ferreri AJ; Møller MB; Parsons BM; Winter JN; Piris MA; Medeiros LJ; Pham LV; Young KH
Aging (Albany NY); 2016 Dec; 8(12):3321-3340. PubMed ID: 27941215
[TBL] [Abstract][Full Text] [Related]
35. Tumor-associated metabolic and inflammatory responses in early stage non-small cell lung cancer: Local patterns and prognostic significance.
Millares L; Barreiro E; Cortes R; Martinez-Romero A; Balcells C; Cascante M; Enguita AB; Alvarez C; Rami-Porta R; Sánchez de Cos J; Seijo L; Monsó E;
Lung Cancer; 2018 Aug; 122():124-130. PubMed ID: 30032820
[TBL] [Abstract][Full Text] [Related]
36. Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients.
Yuan A; Yu CJ; Shun CT; Luh KT; Kuo SH; Lee YC; Yang PC
Int J Cancer; 2005 Jul; 115(4):545-55. PubMed ID: 15704107
[TBL] [Abstract][Full Text] [Related]
37. Differential expression and activation of NF-kappaB family proteins during oral carcinogenesis: Role of high risk human papillomavirus infection.
Mishra A; Bharti AC; Varghese P; Saluja D; Das BC
Int J Cancer; 2006 Dec; 119(12):2840-50. PubMed ID: 16998793
[TBL] [Abstract][Full Text] [Related]
38. miR-675 promotes disease progression of non-small cell lung cancer via activating NF-κB signaling pathway.
Feng Y; Yang C; Hu D; Wang X; Liu X
Cell Mol Biol (Noisy-le-grand); 2017 May; 63(5):7-10. PubMed ID: 28719338
[TBL] [Abstract][Full Text] [Related]
39. A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses.
de Oliveira KA; Kaergel E; Heinig M; Fontaine JF; Patone G; Muro EM; Mathas S; Hummel M; Andrade-Navarro MA; Hübner N; Scheidereit C
Genome Med; 2016 Mar; 8(1):28. PubMed ID: 26988706
[TBL] [Abstract][Full Text] [Related]
40. Transcription factor NF-κB (p50/p50, p65/p65) controls porcine ovarian cells functions.
Pavlová S; Klucska K; Vašíček D; Kotwica J; Sirotkin AV
Anim Reprod Sci; 2011 Oct; 128(1-4):73-84. PubMed ID: 21996578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
